Style | Citing Format |
---|---|
MLA | Rasoolinejad M, et al.. "Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among Hiv Positive Patients in Tehran, Iran." Infectious Disorders - Drug Targets, vol. 19, no. 3, 2019, pp. 297-302. |
APA | Rasoolinejad M, Najafi E, Hadadi A, Najafi M, Kalantari S, Moradmandbadie B, Tayeri K, Seyedalinaghi SA (2019). Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among Hiv Positive Patients in Tehran, Iran. Infectious Disorders - Drug Targets, 19(3), 297-302. |
Chicago | Rasoolinejad M, Najafi E, Hadadi A, Najafi M, Kalantari S, Moradmandbadie B, Tayeri K, Seyedalinaghi SA. "Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among Hiv Positive Patients in Tehran, Iran." Infectious Disorders - Drug Targets 19, no. 3 (2019): 297-302. |
Harvard | Rasoolinejad M et al. (2019) 'Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among Hiv Positive Patients in Tehran, Iran', Infectious Disorders - Drug Targets, 19(3), pp. 297-302. |
Vancouver | Rasoolinejad M, Najafi E, Hadadi A, Najafi M, Kalantari S, Moradmandbadie B, et al.. Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among Hiv Positive Patients in Tehran, Iran. Infectious Disorders - Drug Targets. 2019;19(3):297-302. |
BibTex | @article{ author = {Rasoolinejad M and Najafi E and Hadadi A and Najafi M and Kalantari S and Moradmandbadie B and Tayeri K and Seyedalinaghi SA}, title = {Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among Hiv Positive Patients in Tehran, Iran}, journal = {Infectious Disorders - Drug Targets}, volume = {19}, number = {3}, pages = {297-302}, year = {2019} } |
RIS | TY - JOUR AU - Rasoolinejad M AU - Najafi E AU - Hadadi A AU - Najafi M AU - Kalantari S AU - Moradmandbadie B AU - Tayeri K AU - Seyedalinaghi SA TI - Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among Hiv Positive Patients in Tehran, Iran JO - Infectious Disorders - Drug Targets VL - 19 IS - 3 SP - 297 EP - 302 PY - 2019 ER - |